Evidence map›Paper›PMID 23530398›Full record

ArticleOncology (Williston Park, N.Y.)2013

Ethical challenges in oncology, explored through a series of vignettes.

Laura Tenner, Paul R Helft

Abstract read
PubMed
In one paragraph

Article in Oncology (Williston Park, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Therapeutic breakthroughs in oncology: Enhancing treatment and management.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Laura TennerIndiana University School of Medicine, Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202, USA. tenner2@iupui.edu
Paul R Helft

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The specialty of medical oncology poses many ethical dilemmas to the practicing physician. In this article, we have chosen to focus on three of those challenges, presenting them in the form of vignettes. The first dilemma deals with the difficulties physicians encounter secondary to the rising cost of cancer therapies when choosing and communicating about treatment plans with patients. The second scenario addresses difficulties associated with communicating prognosis to cancer patients, and the third challenge focuses on cancer treatment strategies for patients nearing the end of life.

Indexed as

CommunicationHealth Care CostsHumansMedical OncologyPrognosis

Identifiers

PMID23530398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.